STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Peraso (PRSO) Schedule 13G/A: Iroquois, Abbe and Page disclose warrant positions

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Peraso Inc. received a Schedule 13G/A in which Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page report warrants and beneficial ownership rights for Peraso common stock. The filing discloses reported securities to purchase a combined 1,428,570 shares, with reported allocations of 371,424 shares to Iroquois, 1,057,146 shares attributable solely to Mr. Abbe and 371,424 shares attributable to Ms. Page, and shows shared interests of 371,424 shares among the parties.

The filing states the percentages were calculated using 5,027,173 shares outstanding and reports 9.99% for Mr. Abbe and 6.88% for Iroquois and Ms. Page. The reported warrants are subject to a 9.99% blocker, and the cover-page counts reflect shares issuable upon full exercise without applying the blocker, meaning the actual exercisable ownership will be lower. The filers certify these securities were not acquired to change or influence control of the issuer.

Positive

  • Transparent disclosure of warrant-based positions and allocation among reporting persons
  • Clear statement that the securities were not acquired to change or influence issuer control
  • Explicit disclosure of the 9.99% blocker and the share base used to compute percentages

Negative

  • Potential dilution risk from warrants exercisable into 1,428,570 shares if exercised within blocker limits
  • Concentration near 9.99% for Richard Abbe could be material to governance or voting outcomes if exercised to the blocker threshold
  • Reported counts do not net blockers, which may overstate the theoretical maximum ownership if read without the filing's caveat

Insights

TL;DR Significant warrant positions reported: aggregate rights for 1,428,570 Peraso shares, with one reporting person at the 9.99% threshold.

The Schedule 13G/A documents material derivative exposure via warrants rather than current outright equity holdings. Using the issuer's disclosed outstanding share base of 5,027,173 shares, the filing presents a reported 9.99% stake for Richard Abbe and 6.88% for Iroquois and Kimberly Page, but also makes clear the reported counts do not net the 9.99% blocker. For analysts, the key implications are potential dilution if warrants are exercised within blocker limits and clarity on voting/dispositive allocation between sole and shared authority.

TL;DR Large warrant positions disclosed with an explicit certification of non-control intent and a legal blocker limiting exercise above 9.99%.

The filing emphasizes that the reported securities are derivative instruments subject to a contractual 9.99% blocker and includes a certification that the positions were not acquired to influence control. Governance review should note the filing discloses both sole and shared voting/dispositive powers, with Mr. Abbe shown as holding sole voting/dispositive power over 1,057,146 shares and shared power over 371,424 shares. The disclosure is procedurally complete and flags the blocker constraint that limits immediate governance influence.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: 71,424 shares of Common Stock issuable upon exercise of Warrants (See Item 4)* * As more fully described in Item 4, the Warrants are subject to a 9.99% blocker and the percentage set forth in row (11) gives effect to such blockers. However, as more fully described in Item 4, the securities reported in rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon full exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (6), (8) and (9).


SCHEDULE 13G




Comment for Type of Reporting Person: 1,428,570 shares of Common Stock issuable upon exercise of Warrants (See Item 4)* * As more fully described in Item 4, the Warrants are subject to a 9.99% blocker and the percentage set forth in row (11) gives effect to such blockers. However, as more fully described in Item 4, the securities reported in rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon full exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (6), (8) and (9).


SCHEDULE 13G




Comment for Type of Reporting Person: 371,424 shares of Common Stock issuable upon exercise of Warrants (See Item 4)* * As more fully described in Item 4, the Warrants are subject to a 9.99% blocker and the percentage set forth in row (11) gives effect to such blockers. However, as more fully described in Item 4, the securities reported in rows (6), (8) and (9) show the number of shares of Common Stock that would be issuable upon full exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (6), (8) and (9).


SCHEDULE 13G



Iroquois Capital Management, LLC
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe, President
Date:08/12/2025
Richard Abbe
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe, President
Date:08/12/2025
Kimberly Page
Signature:/s/ Kimberly Page
Name/Title:Kimberly Page
Date:08/12/2025

FAQ

How many Peraso (PRSO) shares are reported as issuable upon exercise of warrants?

The filing reports a combined 1,428,570 shares issuable upon exercise of reported warrants, allocated as 1,057,146 to Mr. Abbe and 371,424 to Iroquois/Ms. Page.

What percentage of Peraso does this reported position represent?

The filing shows 9.99% for Richard Abbe and 6.88% for Iroquois Capital and Kimberly Page, using a share base of 5,027,173 shares outstanding.

Are the reported warrants subject to any exercise limits?

Yes. The reported warrants are subject to a 9.99% blocker, which prevents exercise to the extent it would result in beneficial ownership above 9.99%.

Do the filers claim an intent to influence control of Peraso (PRSO)?

No. The certification in the filing states the securities were not acquired and are not held to change or influence control of the issuer.

On what share count are the percentages based?

Percentages are based on 5,027,173 shares of common stock issued and outstanding as disclosed in the company's public report referenced in the filing.
Peraso

NASDAQ:PRSO

PRSO Rankings

PRSO Latest News

PRSO Latest SEC Filings

PRSO Stock Data

8.41M
9.14M
2.08%
10.73%
0.18%
Semiconductors
Semiconductors & Related Devices
Link
United States
SAN JOSE